Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizosaccharomyces | 28 | 2023 | 104 | 8.580 |
Why?
|
| DNA Replication | 21 | 2022 | 228 | 6.920 |
Why?
|
| Replication Origin | 13 | 2022 | 35 | 5.290 |
Why?
|
| Schizosaccharomyces pombe Proteins | 20 | 2023 | 73 | 4.240 |
Why?
|
| DNA Damage | 12 | 2017 | 279 | 2.860 |
Why?
|
| DNA Replication Timing | 8 | 2022 | 16 | 2.790 |
Why?
|
| S Phase | 12 | 2021 | 74 | 2.570 |
Why?
|
| Gene Expression Regulation, Fungal | 10 | 2017 | 125 | 2.090 |
Why?
|
| Cell Cycle Proteins | 11 | 2024 | 384 | 2.040 |
Why?
|
| Cell Size | 3 | 2021 | 40 | 1.960 |
Why?
|
| Mitosis | 4 | 2024 | 208 | 1.850 |
Why?
|
| Minichromosome Maintenance Proteins | 3 | 2021 | 4 | 1.760 |
Why?
|
| Genome, Fungal | 6 | 2021 | 40 | 1.180 |
Why?
|
| Chromosomal Proteins, Non-Histone | 4 | 2024 | 168 | 1.150 |
Why?
|
| Cell Division | 3 | 2019 | 443 | 1.050 |
Why?
|
| Thymidine | 3 | 2015 | 25 | 1.020 |
Why?
|
| DNA, Fungal | 5 | 2017 | 57 | 1.020 |
Why?
|
| Chromatin | 5 | 2022 | 599 | 0.960 |
Why?
|
| S Phase Cell Cycle Checkpoints | 2 | 2017 | 3 | 0.940 |
Why?
|
| Eukaryotic Cells | 2 | 2023 | 57 | 0.930 |
Why?
|
| DNA-Binding Proteins | 7 | 2011 | 1151 | 0.880 |
Why?
|
| Cell Cycle Checkpoints | 3 | 2017 | 46 | 0.860 |
Why?
|
| Models, Biological | 7 | 2021 | 1140 | 0.820 |
Why?
|
| Replicon | 1 | 2022 | 1 | 0.790 |
Why?
|
| Cyclin B | 1 | 2021 | 17 | 0.730 |
Why?
|
| Signal Transduction | 6 | 2012 | 2888 | 0.720 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2010 | 78 | 0.690 |
Why?
|
| Evolution, Molecular | 5 | 2013 | 298 | 0.650 |
Why?
|
| Genome, Human | 1 | 2021 | 222 | 0.640 |
Why?
|
| Cell Enlargement | 1 | 2019 | 9 | 0.640 |
Why?
|
| G2 Phase | 4 | 2017 | 23 | 0.640 |
Why?
|
| DNA | 4 | 2024 | 806 | 0.620 |
Why?
|
| DNA Helicases | 3 | 2022 | 187 | 0.600 |
Why?
|
| Chromosomes | 2 | 2024 | 135 | 0.590 |
Why?
|
| Molecular Biology | 2 | 2017 | 66 | 0.590 |
Why?
|
| Genetics, Microbial | 1 | 2017 | 11 | 0.560 |
Why?
|
| Eukaryota | 2 | 2016 | 29 | 0.550 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2017 | 41 | 0.550 |
Why?
|
| Models, Genetic | 3 | 2013 | 255 | 0.530 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 188 | 0.530 |
Why?
|
| Estradiol | 1 | 2017 | 247 | 0.510 |
Why?
|
| Stochastic Processes | 3 | 2012 | 25 | 0.500 |
Why?
|
| Kinetics | 6 | 2019 | 750 | 0.490 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 650 | 0.460 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2017 | 116 | 0.450 |
Why?
|
| Staining and Labeling | 1 | 2015 | 123 | 0.450 |
Why?
|
| Sequence Analysis, DNA | 2 | 2012 | 393 | 0.430 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2021 | 537 | 0.400 |
Why?
|
| Checkpoint Kinase 2 | 5 | 2016 | 24 | 0.390 |
Why?
|
| CDC2 Protein Kinase | 2 | 2012 | 33 | 0.370 |
Why?
|
| Genome | 1 | 2013 | 257 | 0.360 |
Why?
|
| Cell Cycle | 4 | 2017 | 382 | 0.360 |
Why?
|
| DNA Repair | 2 | 2009 | 242 | 0.340 |
Why?
|
| Protein Binding | 4 | 2021 | 1554 | 0.330 |
Why?
|
| Methyl Methanesulfonate | 3 | 2017 | 5 | 0.330 |
Why?
|
| Rad51 Recombinase | 1 | 2008 | 26 | 0.310 |
Why?
|
| Epistasis, Genetic | 1 | 2008 | 42 | 0.310 |
Why?
|
| Endonucleases | 1 | 2008 | 80 | 0.300 |
Why?
|
| Homeostasis | 2 | 2021 | 346 | 0.290 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 194 | 0.290 |
Why?
|
| Nucleosomes | 3 | 2016 | 184 | 0.280 |
Why?
|
| Species Specificity | 3 | 2013 | 328 | 0.280 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1547 | 0.260 |
Why?
|
| Chromosome Segregation | 2 | 2024 | 39 | 0.260 |
Why?
|
| Tyrosine | 1 | 2006 | 92 | 0.260 |
Why?
|
| Transcription, Genetic | 5 | 2017 | 844 | 0.260 |
Why?
|
| Animals | 7 | 2024 | 19601 | 0.230 |
Why?
|
| Transcription Factors | 2 | 2011 | 1470 | 0.230 |
Why?
|
| Transcription Initiation Site | 2 | 2021 | 48 | 0.220 |
Why?
|
| Chromosomal Instability | 2 | 2017 | 20 | 0.220 |
Why?
|
| Exodeoxyribonucleases | 3 | 2010 | 28 | 0.220 |
Why?
|
| Coloring Agents | 1 | 2023 | 53 | 0.210 |
Why?
|
| Flow Cytometry | 4 | 2009 | 639 | 0.210 |
Why?
|
| Benchmarking | 1 | 2023 | 135 | 0.200 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2015 | 35 | 0.200 |
Why?
|
| Bromodeoxyuridine | 2 | 2015 | 40 | 0.200 |
Why?
|
| Humans | 11 | 2024 | 59280 | 0.190 |
Why?
|
| Origin Recognition Complex | 1 | 2021 | 3 | 0.190 |
Why?
|
| Mammals | 1 | 2022 | 208 | 0.180 |
Why?
|
| Indoleacetic Acids | 1 | 2021 | 31 | 0.180 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2021 | 43 | 0.180 |
Why?
|
| Computational Biology | 2 | 2013 | 331 | 0.180 |
Why?
|
| Meiosis | 2 | 2011 | 62 | 0.170 |
Why?
|
| HeLa Cells | 1 | 2021 | 523 | 0.170 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2023 | 653 | 0.160 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2019 | 5 | 0.160 |
Why?
|
| Genomic Instability | 2 | 2017 | 53 | 0.160 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 331 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 806 | 0.160 |
Why?
|
| Microscopy, Video | 1 | 2019 | 37 | 0.160 |
Why?
|
| Molecular Sequence Data | 4 | 2011 | 1949 | 0.150 |
Why?
|
| Fungal Proteins | 2 | 2017 | 144 | 0.150 |
Why?
|
| Phylogeny | 3 | 2023 | 336 | 0.150 |
Why?
|
| Chromosomes, Fungal | 3 | 2016 | 35 | 0.150 |
Why?
|
| Tetrahymena | 1 | 2017 | 7 | 0.150 |
Why?
|
| Spliceosomes | 1 | 2018 | 41 | 0.140 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2017 | 3 | 0.140 |
Why?
|
| Mycology | 2 | 2009 | 7 | 0.140 |
Why?
|
| Replication Protein A | 1 | 2017 | 13 | 0.140 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 716 | 0.140 |
Why?
|
| Bleomycin | 1 | 2017 | 32 | 0.140 |
Why?
|
| Centromere | 2 | 2023 | 38 | 0.140 |
Why?
|
| Cell Biology | 1 | 2017 | 21 | 0.140 |
Why?
|
| Recombination, Genetic | 2 | 2009 | 238 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2017 | 6 | 0.140 |
Why?
|
| Erythroid Cells | 1 | 2017 | 9 | 0.140 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1368 | 0.140 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 62 | 0.140 |
Why?
|
| Transcriptome | 2 | 2018 | 338 | 0.140 |
Why?
|
| Interphase | 1 | 2017 | 68 | 0.140 |
Why?
|
| Aneuploidy | 1 | 2017 | 40 | 0.140 |
Why?
|
| Mutation | 3 | 2010 | 2452 | 0.130 |
Why?
|
| Telomere | 2 | 2009 | 50 | 0.130 |
Why?
|
| RNA, Fungal | 2 | 2018 | 38 | 0.130 |
Why?
|
| Cell Wall | 1 | 2016 | 112 | 0.120 |
Why?
|
| Sex Determination Analysis | 1 | 1995 | 5 | 0.120 |
Why?
|
| Nucleotide Motifs | 2 | 2012 | 50 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 159 | 0.120 |
Why?
|
| Helminth Proteins | 1 | 1995 | 39 | 0.120 |
Why?
|
| Genes, Helminth | 1 | 1995 | 53 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 144 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 262 | 0.110 |
Why?
|
| Cell Nucleus | 2 | 2008 | 606 | 0.110 |
Why?
|
| Binding Sites | 2 | 2012 | 881 | 0.100 |
Why?
|
| Feedback, Physiological | 1 | 2012 | 59 | 0.100 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 21 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2008 | 425 | 0.100 |
Why?
|
| Base Sequence | 4 | 2011 | 1300 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2010 | 358 | 0.090 |
Why?
|
| Genes, Mating Type, Fungal | 1 | 2011 | 6 | 0.090 |
Why?
|
| Heterochromatin | 1 | 2012 | 84 | 0.090 |
Why?
|
| Protein Kinases | 2 | 2010 | 142 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1995 | 618 | 0.090 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 284 | 0.090 |
Why?
|
| RNA, Antisense | 1 | 2011 | 49 | 0.090 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2011 | 37 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2011 | 61 | 0.090 |
Why?
|
| Algorithms | 2 | 2018 | 976 | 0.090 |
Why?
|
| RNA, Untranslated | 1 | 2011 | 101 | 0.090 |
Why?
|
| DNA Transposable Elements | 1 | 2011 | 126 | 0.090 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1995 | 397 | 0.090 |
Why?
|
| Genes, Fungal | 1 | 2010 | 56 | 0.080 |
Why?
|
| Probability | 1 | 2010 | 166 | 0.080 |
Why?
|
| Cell Separation | 1 | 2009 | 145 | 0.080 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 42 | 0.080 |
Why?
|
| Spores, Fungal | 1 | 2009 | 15 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 381 | 0.080 |
Why?
|
| Suppression, Genetic | 1 | 2008 | 25 | 0.080 |
Why?
|
| Microbial Viability | 1 | 2009 | 55 | 0.080 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2008 | 23 | 0.080 |
Why?
|
| Hydroxyurea | 1 | 2008 | 19 | 0.080 |
Why?
|
| Endodeoxyribonucleases | 2 | 2010 | 41 | 0.080 |
Why?
|
| Caenorhabditis elegans | 1 | 1995 | 623 | 0.070 |
Why?
|
| Genomics | 1 | 2011 | 318 | 0.070 |
Why?
|
| Temperature | 1 | 2009 | 295 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2010 | 882 | 0.070 |
Why?
|
| Glucose | 1 | 2011 | 445 | 0.070 |
Why?
|
| Plasmids | 1 | 2008 | 279 | 0.070 |
Why?
|
| RNA | 1 | 2011 | 400 | 0.070 |
Why?
|
| Cell Survival | 1 | 2009 | 559 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2003 | 1552 | 0.070 |
Why?
|
| Time Factors | 3 | 2010 | 3614 | 0.070 |
Why?
|
| Transformation, Genetic | 1 | 2006 | 27 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 105 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 855 | 0.060 |
Why?
|
| Phenotype | 1 | 2009 | 1136 | 0.060 |
Why?
|
| Genotype | 1 | 2006 | 617 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2003 | 169 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 160 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 356 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2016 | 292 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2004 | 378 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 750 | 0.040 |
Why?
|
| Introns | 1 | 2018 | 104 | 0.040 |
Why?
|
| Karyotype | 1 | 2017 | 16 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2017 | 60 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2018 | 112 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2018 | 159 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 297 | 0.030 |
Why?
|
| Disorders of Sex Development | 1 | 1995 | 11 | 0.030 |
Why?
|
| Gastrula | 1 | 1995 | 12 | 0.030 |
Why?
|
| Dosage Compensation, Genetic | 1 | 1995 | 22 | 0.030 |
Why?
|
| RNA, Helminth | 1 | 1995 | 46 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1995 | 248 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 1995 | 169 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1995 | 122 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 488 | 0.030 |
Why?
|
| Ascomycota | 1 | 2011 | 11 | 0.020 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2010 | 8 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2011 | 288 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 243 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 326 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 294 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1995 | 1464 | 0.020 |
Why?
|
| Neoplasms | 1 | 2017 | 1240 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 127 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 289 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 10251 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 352 | 0.010 |
Why?
|
| Female | 1 | 2017 | 30694 | 0.010 |
Why?
|
| Male | 1 | 1995 | 27726 | 0.010 |
Why?
|